KANK4

Model summary

A human cytosolic scaffold that uses an N-terminal KN motif and a C-terminal ankyrin-repeat array to assemble inhibitory complexes controlling developmental signaling and transcription. By organizing multivalent protein-binding assemblies, it dampens Notch pathway output and promotes repression of downstream transcriptional programs. Its soluble architecture and interactions with cytoskeletal adaptors position it in the cytosol and at the microtubule apparatus, where it coordinates signaling attenuation with cell-cycle–linked structures.

Predicted Gene Ontology terms

1. 01

   I begin with the InterPro architecture.

   An N-terminal conserved site IPR021939 (Kank N-terminal motif, residues 24–62) precedes a long central-to-C-terminal scaffold defined by IPR047184 (KN motif and ankyrin repeat domain-containing protein 1–4 family, residues 246–992). The C-terminal half is dominated by ankyrin modules: a broad ankyrin repeat-containing superfamily IPR036770 (residues 746–988) that encompasses tandem ankyrin repeats IPR002110 (repeat units, residues 811–890 and 895–984). This ordered layout—an N-terminal KN motif followed by an extended ankyrin-repeat platform—creates a modular, non-enzymatic scaffold optimized for multivalent protein binding. Ankyrin repeats form elongated grooves that capture short linear motifs from diverse partners, and the KN motif typically nucleates complex assembly. This architecture causally dictates a molecular function centered on GO:0005515 protein binding.

2. 02

   From this binding-centric core, I infer how signaling pathways are regulated.

   Ankyrin-repeat scaffolds frequently gate developmental signaling cascades by sequestering transcriptional regulators or endocytic/trafficking components. The KN–ankyrin framework can assemble inhibitory complexes that attenuate the Notch pathway, aligning with GO:0045746 negative regulation of Notch signaling pathway. By stabilizing repressor assemblies or by diverting Notch effectors away from nuclear targets, the scaffold reduces transcriptional output downstream of RNA polymerase II, supporting GO:0000122 negative regulation of transcription by RNA polymerase II. Thus, the domain architecture explains both the inhibitory signaling role and the transcriptional repression phenotype.

3. 03

   Cellular placement follows from the same scaffold logic.

   The absence of catalytic domains and the presence of extensive ankyrin repeats favor soluble assemblies that traffic between compartments. The KN motif often seeds cytosolic complexes, consistent with GO:0005829 cytosol. The ankyrin platform can also dock onto cytoskeletal adaptors; coupling to spindle and spindle-associated assemblies rationalizes localization to the GO:0015630 microtubule cytoskeleton. This cytosol-to-microtubule axis provides a route by which the protein influences both signaling and cell-cycle-linked checkpoints.

4. 04

   Mechanistically, I hypothesize that the N-terminal KN motif nucleates assembly of inhibitory hubs that capture Notch pathway components and transcriptional repressors, while the C-terminal ankyrin array confers avidity and specificity.

   In the cytosol, the scaffold likely binds endocytic and cytoskeletal adaptors to tune Notch receptor trafficking and the availability of nuclear effectors. At microtubules, it may coordinate with spindle-associated proteins to synchronize pathway repression with cell-cycle status. Likely partners include Notch receptors and ligands (as cargo), cytosolic endocytic adaptors, and microtubule-associated proteins that together enforce pathway attenuation and transcriptional downregulation.